 This is a pilot study in a patient population with suspected Coronary Artery Disease CAD as defined by the presence of an abnormal nuclear PETSPECT perfusion scan. In this study design, PETSPECT will serve as the comparative standard for presence of myocardial ischemia. We intend to determine the accuracy of a novel MR technique for localization of perfusion deficits in comparison to PETSPECT. 